# Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver Disease

> **NCT03072667** · — · APPROVED_FOR_MARKETING · sponsor: **Catherine Cibulskis, MD**

## Conditions studied

- Cholestasis
- Liver Diseases

## Interventions

- **DRUG:** Omegaven

## Key facts

- **NCT ID:** NCT03072667
- **Lead sponsor:** Catherine Cibulskis, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2018-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03072667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03072667, "Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver Disease". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT03072667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*